, Volume 44, Issue 9, pp 725–733 | Cite as

The nutritional incidence of flavonoids: some physiological and metabolic considerations

  • C. Regnault Roger


Examination of the physiological activity of flavonoids in relation to their antiscorbutic properties shows that some of these compounds, the flavan-3=ols, have a particular nutritional impact and consequently should be distinguished from the rest of the flavonoids and polyphenolds. Therefore, the use of the term ‘Vitamin P’ and ‘Bioflavonoids’ is also discussed.

Key words

Vitamin P polyphenols flavonoids nutritional role physiological properties 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ames, B. N., McCann, J., and Yamasaki, E., Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat. Res.31 (1975) 347–367.Google Scholar
  2. 2.
    Armentano, L. von, Bensatz, A., Beres, T., Rusnyak, T., and Szent Györgyi, A., Über den Einfluß von Substanzen der Flavongruppe auf die Permeabilität der kapillaren Vitamin P. Dtsch. med. Wschr.62 (1936) 1325–1328.Google Scholar
  3. 3.
    Axelrod, J., and Laroche, J. M., Inhibitors of O-methylation of epinephrine and norepinephrine in vitro and in vivo. Sciences130 (1958) 800.Google Scholar
  4. 4.
    Axelrod, J., and Thomchick, R., Enzymic O-methylation of epinephrine and other catechols. J. biol. Chem.233 (1958) 702–705.Google Scholar
  5. 5.
    Barnes, M. J., Function of ascorbic acid in collagen metabolism. Ann. N.Y. Acad. Sci.258 (1975) 264–277.Google Scholar
  6. 6.
    Basarkar, P. N., and Nath, N., Cholesterol lowering action of vitamin P-like compounds in rats. Indian J. exp. Biol.19 (1981) 787–789.Google Scholar
  7. 7.
    Bauman, J., Bruchausen, F. V., and Wurm, G., Flavonoids and related compounds as inhibitors of arachidonic acid peroxidation. Prostaglandins20 (4) (1980) 627–639.Google Scholar
  8. 8.
    Beaton, G. H., Hellebust, D. M., Paul, W., and Wright, A. M., The effect of scurvy on thyroid activity. J. Nutr.70 (1960) 321.Google Scholar
  9. 9.
    Benko, S., Gabor, M., Varkonyi, T., Antal, A., and Foldi, M., Brain cedema and subpleural haemorrhages in experimental P avitaminosis. Physiol. Chem. Phys.2 (1970) 110.Google Scholar
  10. 10.
    Bensath, A., Ruysnyak, T., and Szent Györgyi, A., Vitamin nature of flavones. Nature138 (1936) 793–798.Google Scholar
  11. 11.
    Bensath, A., Ruysnyak, T., and Szent Györgyi, A., Vitamin P. Nature139 (1937) 326–327.Google Scholar
  12. 12.
    Bensath, A., and Szent Györgyi, A., Vitamin P. Nature140 (1937) 426.Google Scholar
  13. 13.
    Beretz, A., Anton, R., and Cazenave, J. P., The effects of flavonoids on cyclic nucleotide phosphodiesterases, in: Plants Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships, pp. 281–296. Eds V. Cody, E. Middleton Jr, J. B. Harborne. Alan Riss Inc, New York 1986.Google Scholar
  14. 14.
    Beretz, A., Cazenave, J. P., and Anton, R., Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships. Agents Actions12 (3) (1982) 382–387.Google Scholar
  15. 15.
    Bezssonoff, N., L'effet antiscorbutique est-il dû à deux substances différentes? C.r. Acad. Sci. Paris183 (1926) 1309; Bull. Soc. Chim. Biol.9 (1927) 568.Google Scholar
  16. 16.
    Blaske, E., and Hertting, G., Enzymatic methylation of l-ascorbic acid by COMT. Biochem. Pharmac.20 (1970) 1363–1370.Google Scholar
  17. 17.
    Blumenkranzt, N., and Asboe-Hansen, G., Effect of (+)catechin on collagen biosynthesis. IRCS med. Sci.: Biochem. connective skin and bone3 (1975) 573.Google Scholar
  18. 18.
    Blumenkrantz, N., and Asboe-Hansen, G., Studies on the effect of (+)catechin on connective tissue in the guinea pig and in organ culture. Scand. J. Rheumat.7 (1978) 55–60.Google Scholar
  19. 19.
    Blumenkrantz, N., and Asboe-Hansen, G., Effect of (+)catechin on connective tissue. Scand. J. Rheumat.9 (1980) 1–5.Google Scholar
  20. 20.
    Bohm, K. von, Die Flavonoide. Arzneimittel-Forsch.53 (1959) 647–778 and54 (1960) 139–160.Google Scholar
  21. 21.
    Borchardt, R. T., and Huber, J. A., Structure-activity relationship for inhibition by flavonoid. J. med. Chem.18 (1) (1975) 120–122.Google Scholar
  22. 22.
    Borsook, H., Davenport, H. W., Jeffrey, C. E. P., and Warner, R. C., The oxidation of ascorbic acid and its reduction in vitro and in vivo. J. biol. Chem.117 (1937) 237–279.Google Scholar
  23. 23.
    Bowers-Komro, D. M., McCormick, D. B., King, G. A., Sweeny, J. G., and Lacobucci, G. A., Confirmation of 2-O methyl ascorbic acid as the product from enzymatic methylation of l-ascorbic acid by catechol-O-methyl transferase. Int. J. Nutr. Res.52 (1982) 186–193.Google Scholar
  24. 24.
    Brown, J. P., A review of genetic effects of naturally occuring flavonoids, anthraquinones and related compounds. Mutat. Res.75 (1980) 243–277.Google Scholar
  25. 25.
    Brucker, V., and Szent Györgyi, A., Chemical nature of citrine. Nature (London)138 (1936) 1057.Google Scholar
  26. 26.
    Cardinale, G. J., Strassen, F. L., Ramadasan, K., and Underfriend, S., Activation of prolylhydroxylase in fibroblast by ascorbic acid. Ann. N.Y. Acad. Sci.258 (1975) 278–287.Google Scholar
  27. 27.
    Cetta, G., Gerzeli, G., Quartieri, A., and Castellani, A. A., Protective effect of flavonoid on the collagen of lathyric rat. Experientia27 (1971) 1046–1048.Google Scholar
  28. 28.
    Chamrai, E., La vitamine P (polyphenol végétal), sa nature chimique et son mécanisme d'action physiologique. J. Physiol. Paris61 (1969) 69–83.Google Scholar
  29. 29.
    Clark, W. G., and Geissman, T. A., Potentiation of effects of epinephrine by flavonoids (vitamin P-like) compounds. Relation of structure to activity. J. Pharmac. exp. Ther.95 (1947) 363–381.Google Scholar
  30. 30.
    Crook, E. M., and Hopkins, F. G., Further observations on the system ascorbic acid glutathione, ascorbic acid oxydase. Biochem. J.30 (2) (1938) 1356–1363.Google Scholar
  31. 31.
    Das, N. P., Flavonoids metabolism. Excretion of m-hydroxyphenylhydracrylic acid from (+)catechin in the monkey. Drug Metab. Disposition: Biol. Fate Chem.2 (3) (1974) 209–213.Google Scholar
  32. 32.
    Fabianek, J., Vitamine P: régime artificiel pour le cobaye. Bull. Soc. Chim. Biol.36 (1954) 851–858.Google Scholar
  33. 33.
    Fabianek, J., Recherche en vue de l'établissement d'un régime purifié convenant au cobaye. Archs Sci. Physiol.15 (1961) 221.Google Scholar
  34. 34.
    Fabianek, J., Neumann, J., and Lavollay, J., Théorie sur la vitamine P. Prévention de la fragilité et des hémorragies capillaires de l'acide ascorbique. C.r. Acad. Sci. Paris234 (1952) 894–896.Google Scholar
  35. 35.
    Filipi, L., O bioflavonoidii. Bull. Chim. Farm.95 (1956) 530–539.Google Scholar
  36. 36.
    Fluck, H., Flavonoide und Flavonoiddrogen als Heilmittel. Schweiz. Apoth. Ztg.96 (1958) 733–759.Google Scholar
  37. 37.
    Gabor, M., Pharmacologic effects of flavonoids on blood vessels. Angiologica9 (1972) 355–374.Google Scholar
  38. 38.
    Gazave, J. M., Contribution à l'étude du deuxième facteur antiscorbutique. J. Physio. Paris58, Suppl. 1 (1966) 128.Google Scholar
  39. 39.
    Gazave, J. M., Ancla, M., and Canu, P., Role of basement and cell membranes in the maintenance of the integrity of blood capillary wall, in: Permeability and Function of Biological Membranes, pp. 355–360. Eds L. Bolis et al. North Holland Publishers 1970.Google Scholar
  40. 40.
    Gazave, J. M., Ancla, M., Arhan, P., Canu, P., and Parrot, J. L., Recherche sur la vitamine C2. Son rôle au niveau de la paroi des capillaires sanguins. J. Physiol. Paris62, Supp. 2 (1970) 279.Google Scholar
  41. 41.
    Gazave, J. M., de Montaut, F., Regnault Roger, C., and Parrot, J. L., Original method of showing some constitutive elements of capillary walls. Biochem. exp. Biol.14 (1) (1978) 25–31.Google Scholar
  42. 42.
    Gazave, J. M., Regnault Roger, C., and Parrot, J. L., Compétiteurs de la méthylation des catécholamines circulantes. Proc. Int. U. Physiol. Sci. XIII726 (1977) 259.Google Scholar
  43. 43.
    Gazave, J. M., Roger, C., de Montaut, F., and Parrot, J. L., Localisation de l'acide ascorbique dans la paroi des capillaires sanguins. Annls pharm. fr.33 (11) (1975) 545–550.Google Scholar
  44. 44.
    Gazave, J. M., Roger, C., Achard, M., and Parrot, J. L., Polyphénols et résistance capillaire. Bull. Groupe Polyphénols5 (1975) 5.Google Scholar
  45. 45.
    Gazave, J. M., Truchaud, M., Parrot, J. L., Achard, M., and Roger, C., Perspectives nouvelles sur le catabolisme de l'acide ascorbique. Annls pharm. fr.33 (3–4) (1975) 155–161.Google Scholar
  46. 46.
    Geissmann, T. A., and Hinreiner, E., Theories on the biogenesis of flavonoid compounds. Bot. Rev.18 (1952) 77.Google Scholar
  47. 47.
    Gendre, P., Lapparra, J., and Barraud, E., Effet protecteur des oligomères procyanidoliques sur le lathyrisme expérimental chez le rat. Annals pharm. fr.43 (1) (1985) 61–71.Google Scholar
  48. 48.
    Gendre, P., Pinon, J. F., and Durandeau, C., Etude infrastructurale de l'action de certains flavonoides sur le lathyrisme expérimental chez la souris. Annls pharm. fr.35 (5–6) (1977) 161–172.Google Scholar
  49. 49.
    Griffiths, L. A., Mammalian metabolism of flavonoids, in: The Flavonoids: Advances in Research, pp. 681–718. Eds J. B. Harbone and T. J. Mabry. Chapman and Hall, London 1982.Google Scholar
  50. 50.
    Gugler, R., Leschick, M., and Dengler, H. J., Disposition of quercetin in man after single oral and intravenous doses. Eur. J. clin. Pharmac.9 (1975) 229–234.Google Scholar
  51. 51.
    Hacklett, A. M., The metabolism of flavonoid compounds in mammals, in: Plants Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure Relationships, pp. 177–194. Eds V. Cody, E. Middleton Jr and J. B. Harbone. Alan Riss Inc, New York 1986.Google Scholar
  52. 52.
    Haley, T. J., Clark, W. C., and Geissman, T. A., Studies on vitamin P. Proc. Soc. exp. Biol. (New York)65 (1947) 202–207.Google Scholar
  53. 53.
    Haslam, E., Proanthocyanidins, in: The Flavonoids: Advances in Research, pp. 417–447. Eds J. B. Harbone and T. J. Mabry. Chapman and Hall, London 1982.Google Scholar
  54. 54.
    Heine, H., and Worden, C., Vitamin C therapy in hyperlipoproteinemia. Int. J. Vit. Nutr. Res. Suppl.19 (1979) 45–54.Google Scholar
  55. 55.
    Hughes, R. E., and Wilson, H. K., Flavonoids: some physiological and nutritional considerations. Prog. med. Chem.14 (1977) 285–301.Google Scholar
  56. 56.
    Hughes, R. E., and Jones, P. R., Natural and synthetic sources of vitamin C. J. Sci. Fd Agric.22 (1971) 551–552.Google Scholar
  57. 57.
    Javilliers, M., and Lavollay, J., Les substances actives sur la résistance et la perméabilité des capillaries et le concept de la vitamine P. Helv. chim. Acta29 (1946) 1283–1289.Google Scholar
  58. 58.
    Jonadet, M., Meunier, M. T., Villie, F., Bastide, J., and Bastide P., Catéchines et oligomères flavanoliques du Cupressus semper Vireus L. Activités inhibitrices vis-à-vis de l'élastase in vitro et activités angioprotectrices comparées in vivo. Annls pharm. fr.42 (2) (1977) 61–167.Google Scholar
  59. 59.
    Kühnau, J., Flavonoid. A class of semi-essential food components. Their role in human nutrition. Wld Rev. Nutr. Diet24 (1976) 117–191.Google Scholar
  60. 60.
    Kursanov, A. L., Bukin, V. N., Povolotskaya, K. L., and Zaprometov, M. N., Biological action of tea tanin. Biokhimiya15 (1950) 337.Google Scholar
  61. 61.
    Landolfi, R., Mower, R., and Steiner, M., Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Biochem. Pharmac.33 (9) (1984) 1525–1530.Google Scholar
  62. 62.
    Lavollay, J., Sur la vitamine P (esculetol). C. r. Acad. Biol. Paris139 (1945) 270.Google Scholar
  63. 63.
    Lavollay, J., Fabianek, J., and Neumann, J., Les flavonoides et les tannoides (vitamine P) ne sont pas des facteurs alimentaires indispensables pour le cobaye. 2ème congrès Int. Biochim. Paris (1952) 329.Google Scholar
  64. 64.
    Lavollay, J., and Neumann, J., Les substances actives contre la fragilité vasculaire. Exposés Ann. Biochim. Med.10 (1949) 58–75.Google Scholar
  65. 65.
    Lavollay, J., and Neumann, J., Les vitamines P, in: Traité de Biochimie Générale, pp. 349–370. Eds J. Polonovski et al. Masson, Paris 1969.Google Scholar
  66. 66.
    Lee, T. P., Matteliano, M. L., and Middleton, E. Jr., Effect of quercetin on human polymorphonuclear leucocyte lysosomal enzyme release and phospholipid metabolism. Life Sci.31 (1982) 2765–2774.Google Scholar
  67. 67.
    Levene, C. I., and Bates, C. J., Ascorbic acid and collagen synthesis in cultured fibrobiasts. Ann. N.Y. Acad. Sci.258 (1975) 288–306.Google Scholar
  68. 68.
    Lewin, S., Recents advances in the molecular biology of vitamin C, in: Vitamin C, pp. 221–252. Eds G. G. Birsh and K. J. Parker. Applied Sci. Publishers, London 1974.Google Scholar
  69. 69.
    Lohman, W., Greulich, W., and Doll, G., On the possible involvement of ascorbic acid and cooper protein in leukemia. (I): Blut39 (1979) 317–326, (II): 327–332; (IV): Z. Naturforsch.34 (1979) 550–554.Google Scholar
  70. 70.
    Lonati-Galligani, M., Galligani, L., and Fuller, G. C., Effect of (+)catechin on purified polylhydroxylase and on collagen synthesis in skin fibroblasts in culture. Biochem. Pharmac.28 (1979) 2573–2578.Google Scholar
  71. 71.
    Mac Gregor, J. T., Mutagenic and carcinogenic effects of flavonoids, in: Plant Flavonoids in Biology and Medicine; Biochemical, Pharmacological and Structure-Activity Relationships, pp. 411–424. Eds V. Cody, E. Middleton Jr and J. B. Harborne. Alan Riss Inc, New York 1986.Google Scholar
  72. 72.
    Mac Gregor, J. T., and Jurd, L., Mutagenicity of plant flavonoids: structural requirements for mutagenic activity in Salmonella typhimurium. Mutat. Res.54 (1978) 297–309.Google Scholar
  73. 73.
    Masquelier, J., Effects physiologiques des constituants non alcooliques du vin. Cah. Nutr. Diet.5 (4) (1970) 57–64.Google Scholar
  74. 74.
    Masquelier, J., Michaud, J., Laparra, J., and Dumon, M. C., Flavonoides et pycnogenols. Int. J. Vit. Nutr. Res.49 (1979) 307–311.Google Scholar
  75. 75.
    Matussis, I. I., Les bioflavonoides sont-ils un facteur essentiel de la nourriture? Voprosypitania24 (1965) 3.Google Scholar
  76. 76.
    Mizuno, A., and Kinoshita, J. H., Diabetic cataracts and flavonoid. Science195 (1977) 205–206.Google Scholar
  77. 77.
    Paris, R. R., and Delaveau, P., Metabolisme et pharmacocinétique des flavonoides. Essais préliminaires avec un C flavonoide, le lespecapitoside. Plantes med. phytother.11 (spécial) (1977) 198–204.Google Scholar
  78. 78.
    Paris, R., and Moury, J., Action sur la perméabilité capillaire de divers flavonoides. Annls pharm. fr.22 (8–9) (1964) 489–493.Google Scholar
  79. 79.
    Parrot, J. L., La vitamine P. Recherches physiologiques. C.r. Soc. Biol. Paris137 (1943) 171.Google Scholar
  80. 80.
    Parrot, J. L., Instruments nouveaux: l'angiostéromètre. Presse Med.29 (1954) 614.Google Scholar
  81. 81.
    Parrot, J. L., and Cotereau, H., Recherche sur l'action physiologique de la vitamine P. Archs int. Physiol.54 (1946) 197.Google Scholar
  82. 82.
    Parrot, J. L., and Cotereau, H., L'économie de l'acide ascorbique dans l'organisme. Rev. int. Vit.27 (3) (1957) 345–364.Google Scholar
  83. 83.
    Parrot, J. L., and Canu, P., Les facteurs qui élévent la résistance capillaire. Archs int. Pharmacodyn.152 (1964) 234–248.Google Scholar
  84. 84.
    Randoin, L., and Lecoq, R., Polynévrite et scorbut chronique. Bull. Soc. Chim. Biol.9 (1927) 513.Google Scholar
  85. 85.
    Regnault Roger, C., Constitution et modes d'action du deuxième facteur antiscorbutique. Thèse ès-sciences naturelles. Université Pierre et Marie Curie-Paris VI (1978) 206.Google Scholar
  86. 86.
    Regnault Roger, C., Gazave, J. M., and Devynk, J., Réduction de l'acide déhydroascorbique par les thiols en présence de biocatalyseurs: étude polarographique. Int. J. Vit. Nutr. Res.52 (1982) 159–168.Google Scholar
  87. 87.
    Ribereau-Gayon, P., Les composés phénoliques des végétaux, p. 254. Dunod, Paris 1968.Google Scholar
  88. 88.
    Ring, K., Ehle, H., Foit, B., and Schwarz, M., The cytoplasmic membrane as a target for (+)catechin and some other flavonoids. Proceed. 5th Hung. Bioflavonoid Symposium. Akademiai Kiado, Budapest 1977; pp. 427–438.Google Scholar
  89. 89.
    Robbins, R. C., Action of flavonoid on blood cell: trimodal action of flavonoids elucidates their inconsistent physiological effects. Int. J. Nutr. Res.44 (1975) 203–216.Google Scholar
  90. 90.
    Robbins, R. C., Action in human blood of methoxylated flavones which confer disease resistance on both plants and animals: concept of a dietary conditioned mechanism of defense against disease. Int. J. Nutr. Res.45 (1977) 52–60.Google Scholar
  91. 91.
    Rodney, G., Swanson, A. L., Wheeler, L. M., Smith, G. N., and Worrel, C. S., The effect of a serie of flavonoid on hyaluronidase and some other related enzymes. J. biol. Chem.183 (1950) 739.Google Scholar
  92. 92.
    Ruckstuhl, M., Beretz, A., Anton, R., and Landry, Y., Flavonoids are selective cyclic GMP phosphodiesterase inhibitors. Biochem. Pharmac.28 (1979) 535–538.Google Scholar
  93. 93.
    Salvayre, R., Affany, A., Negre, A., Lesbordes, P., and Doute-Blazy, L., Comment quantifier in vitro l'effet des médicaments antioxydants. Cah. Nutr. Diet.22 (1987) 55–62.Google Scholar
  94. 94.
    Scarborough, H., Deficiency of vitamins C and P in man. Lancet2 (1940) 644.Google Scholar
  95. 95.
    Scarborough, H., Vitamin P and the vitamin P potency of foodstuff. Biochem. J.39 (1945) 271–278.Google Scholar
  96. 96.
    Schlebusch, H. and Kern, D., Stabilization of collagen by polyphenol. Angiologica9 (1972) 248.Google Scholar
  97. 97.
    Scott, K. G., and Strei, L., Effect of bioflavones on the metabolism of an iodinated compound. Proc. Soc. exp. Biol. New York81 (1952) 493.Google Scholar
  98. 98.
    Shils, M. E., and Goodhart, R. S., Flavonoids in biology and medicine. Nutr. Monog. series 2, New York 1956.Google Scholar
  99. 99.
    Stravic, B., Mutagenic food flavonoids (symposium report). Fedn Proc.43 (1984) 2454.Google Scholar
  100. 100.
    Thompson, M., Williams, C. R., and Elliot, G. E. P., Stability of flavonoid complexes of cooper(II) and flavonoid antioxidant activity. Analyt. chim. Acta85 (1976) 375–381.Google Scholar
  101. 101.
    Varma, S. D., Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications, in: Plants Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships, pp. 343–358. Eds V. Cody, E. Middleton Jr and J. B. Harborne. Alan Riss Inc, New York 1986.Google Scholar
  102. 102.
    Weinges, K., Gorissen, H., and Lontie, R., Les procyanidines dimères naturelles. Ann. Physiol. Veg.11 (1969) 67–82.Google Scholar
  103. 103.
    Welson, A. F., Tobias, L. D., Fiedler-Nagy, C., Anderson, W., Hope, W., Meyers, K., and Coffey, J. W., Effect of flavonoid on arachidonic acid metabolism, in: Plants Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships, pp. 231–242. Eds V. Cody, E. Middleton Jr and J. B. Harborne. Alan Riss Inc, New York 1986.Google Scholar
  104. 104.
    Willaman, T. F., Some biological effects of the flavonoids. J. Am. pharm. Ass.44 (1955) 404.Google Scholar
  105. 105.
    Wilson, H. K., Price-Jones, C., and Hughes, R. E., The influence of an extract of orange peel on the growth and ascorbic acid metabolism of young guinea pigs. J. Sci. Fd Agric.27 (1976) 661–666.Google Scholar
  106. 106.
    Wory, P., Les flavones en thérapeutiques. Scalpel (Bruxelles)116 (1961) 255–259.Google Scholar
  107. 107.
    Yew Man Li, S., Megadose vitamin C supplementation and ascorbic acid and dehydroascorbic levels in plasma and lymphocytes. Nutr. Rep. Int.30 (3) (1984) 597–601.Google Scholar
  108. 108.
    Zloch, Z., Sodlova, A., and Pavlovka, L., The influence of bioflavonoid on the metabolism of vitamin C. Proceed. 5th Hung. Bioflavonoid Symposium. Akademiai Kiado, Budapest 1977; pp. 445–459.Google Scholar

Copyright information

© Birkhäuser Verlag Basel 1988

Authors and Affiliations

  • C. Regnault Roger
    • 1
  1. 1.Chaire de BiochimieConservatoire National des Arts et MétiersParis Cedex 03(France)

Personalised recommendations